Invention Grant
- Patent Title: CDP protein secretion inhibitors
-
Application No.: US17042009Application Date: 2019-03-29
-
Publication No.: US11339193B2Publication Date: 2022-05-24
- Inventor: Dustin McMinn , John William Taunton , Phillip Patrick Sharp
- Applicant: KEZAR LIFE SCIENCES , THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
- Applicant Address: US CA South San Francisco; US CA Oakland
- Assignee: KEZAR LIFE SCIENCES,THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
- Current Assignee: KEZAR LIFE SCIENCES,THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
- Current Assignee Address: US CA South San Francisco; US CA Oakland
- Agency: Marshall, Gerstein & Borun LLP
- International Application: PCT/US2019/024731 WO 20190329
- International Announcement: WO2019/191527 WO 20191003
- Main IPC: C07K11/00
- IPC: C07K11/00 ; C07K11/02 ; A61K38/00 ; A61K45/06

Abstract:
Provided herein are compounds that inhibit protein secretion, e.g., via inhibition of Sec61. Also provided are compositions of the inhibitor compounds, and methods of using these inhibitors. The compounds disclosed herein can be used, e.g., for the treatment of cancer, arthritis, and/or inflammation.
Public/Granted literature
- US20210017233A1 CDP PROTEIN SECRETION INHIBITORS Public/Granted day:2021-01-21
Information query